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Abstract
            It is well established that cardiac resynchronisation therapy (CRT) using biventricular 
pacing prolongs survival by its effects on pump failure. The rate of sudden cardiac death in 
patients undergoing CRT, however, remains high. Animal and human studies have shown that 
reversal of normal sequence of myocardial activation during epicardial pacing, as applied during 
CRT, increases the transmural dispersion of repolarisation (TDR), a substrate for ventricular 
arrhythmias. Cohort studies in humans suggest that CRT has a differential effect on the 
arrhythmogenic substrate, antiarrhythmic in some and proarrhythmic in others. This review the 
focuses   on   the   possibility   that   CRT   may,   under   certain   circumstances,   promote 
arrhythmogenesis. 
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               Cardiac resynchronisation therapy (CRT) using biventricular pacing (BiVP) has 
revolutionised the treatment of heart failure. In the Cardiac Resynchronization Heart Failure 
(CARE-HF) study, which included patients with with a QRS complex ≥120 ms, NYHA class III 
or IV and a left ventricular ejection fraction of ≤35%, CRT was associated with a 36% reduction 
in  all-cause mortality.1  This  and  other  studies  have  shown  that  CRT  also  leads  to an 
improvement in NYHA class, walking distance, quality of life and reverse left ventricular 
remodelling.2-5.  
            The rate of sudden cardiac death remains high in patients with heart failure who are 
treated with CRT.6 In the first report of the CARE-HF study, CRT did not reduce the rate of 
sudden cardiac death.1 In the Comparison of Medical Therapy, Pacing, and Defibrillation in 
Heart Failure (COMPANION) study,  CRT with defibrillator  back-up (CRT-D) led to a 
significant reduction in mortality,4 suggesting that ventricular arrhythmias as the cause of death 
in some patients with heart failure undergoing CRT.                                                                 
               Increasing evidence indicates that the myocardium is electrically and mechanically 
heterogenous. Reversal of normal sequence of myocardial activation following epicardial 
pacing, as  it  occurs  during  CRT,  has  been  shown  to  increase  the  transmural  dispersion  of 
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repolarisation (TDR), a substrate for ventricular arrhythmias.7,8 These issues have raised concern 
as to whether CRT is proarrhythmic. This review explores the effects of epicardial pacing on the 
arrhythmogenic substrate and their relevance to the possible proarrhythmic effects of CRT.
Electrical heterogeneity of the myocardium                                                                     
            The concept of electrical heterogeneity in the myocardium arose from a seminal study in 
1991, in which Sicouri and Antzelevitch described a subpopulation myocardial cells with distinct 
electrophysiological properties, known as M cells.9  Amongst its characteristics, the M cell 
generates an action potential which prolongs to a greater degree than that of the epicardium and 
endocardium when the heart rate slows.9,10  (Figure 1) Electrical heterogeneity has been 
demonstrated in various animal species and in the human myocardium.11 
Figure 1. M-cell action potential duration in response to slowing of the stimulation rate. Transmembrane recordings 
were obtained from epicardial (Epi), endocardial (Endo) portions of the canine right and left ventricles at cycle 
lengths of 300, 1,000, 2,000 and 5,000 ms. Modified and reprinted with permission from Lippincott Williams & 
Wilkins.9
Electrical heterogeneity and the surface ECG                                                                     
            Surrogate measures of electrical heterogeneity can be found in the12-lead ECG, which is, 
in effect, a single image of electrical activity of the myocardium propagated in three dimensions. 
The   QT  interval  is  a  macroscopic   measure   of    ventricular  repolarisation   which  reflects, 
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ultimately, the cellular action potential. The unipolar chest leads from V1 to V6 more accurately 
reflect local activity12 and, for this reason, these leads are used preferentially in the assessment of 
QT   dispersion.  
               The morphology of the T wave reflects voltage gradients generated by epicardial, 
endocardial and M layers. The peak of the T wave corresponds to full repolarisation of the 
epicardial action potential, whereas the end of the T wave coincides with repolarisation of the M 
cells. The length of the QT peak interval therefore depends on the duration of the epicardial 
action potential, whereas the QT interval duration reflects the duration of the M-cell action 
potential.  
            The Tpeak-Tend interval provides a measure of the TDR.8,13-16 A prolonged Tpeak-Tend has 
been linked to spontaneous development of ventricular tachycardia and, interestingly, with 
increased   inducibility.17  In   effect,   a   prolonged   Tpeak-Tend  marks   the   presence   of   an 
arrhythmogenic   substrate.                                                                            
            Although QT dispersion has been shown to predict mortality in population based studies,
18  and in patients with myocardial infarction19  and left ventricular dysfunction20-22, it has 
generally been disappointing as a predictor of arrhythmic events.                                               
Electrical   effects   of   epicardial   pacing                                                            
            The QT interval, the morphology of the T wave and the Tpeak-Tend interval are dependent 
on the activation sequence of the myocardium.  In an elegant study using mathematical 
modelling,   Fish   et   al8  demonstrated   the   difference   between   transmural   conduction   in 
homogenous   versus   heterogenous   myocardium.   (Figure   2)   In   homogenous   myocardium, 
reversing of the direction of stimulation leads to a change in the polarity of the QRS complex 
and the T wave, but not to changes in the duration of the action potential, the QT interval, TDR 
or the Tpeak-Tend interval. In heterogenous myocardium consisting of epicardium, endocardium 
and M cells, reversal of the transmural direction of activation does lead to a prolongation of TDR 
and the Tpeak-Tend interval, reflecting the fact that the epicardium depolarises and repolarises 
earlier and the M calls depolarise and repolarise later. 
            Bai et al studied the effects of epicardial LV pacing and biventricular pacing in an 
experimental model of dilated cardiomyopathy in dogs.23  In control dogs, the mean action 
potential duration was prolonged in the three layers of the myocardium, being shortest in the 
subepicaridum and longest in the mid layer. Left ventricular epicardial and biventricular pacing 
in controls dogs was associated with a prolonged transmural dispersion of repolarisation, 
compared to RV endocardial pacing. The surface ECG showed that LV epicardial pacing 
resulted in a longer Tpeak-Tend compared to RV endocardial pacing. In dogs with DCM, both 
mean action potential duration and transmural dispersion of repolarisation increased with LV-
epicardial and biventricular pacing. This group proposed that such changes could result in the 
formation   of   unidirectional   block   and   re-entry,   a   phenomenon   which   is   linked   to   the 
development of malignant ventricular  arrhythmias.                                                      
 
            In experiments using isolated arterially perfused rabbit LV wedge preparations, Medina-
Ravell et al7 have recently shown that switching from endocardial to epicardial pacing produces 
an increase in QT interval and transmural dispersion of repolarisation, without associated 
increases in ventricular transmembrane action potential durations. Administration of dofetilide, 
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an agent which increases the action potential duration, led to a prolongation of the QT interval 
and TDR, an effect which was more pronounced with epicardial pacing. (Figure 3) In a further 
experiment,   epicardial   pacing   was   shown   to   facilitate   transmural   propagation   of   early 
repolarisations,   the  emergence  of R-on-T extrasystoles  and  torsade-de-pointes  ventricular 
tachycardia. 
Figure 2. Top: Effects of epicardial (Epi) versus endocardial (Endo) pacing on QT interval, Tpeak-end (Tp-Te) and 
TDR in homogenous myocardium and in heterogenous myocardium. Note that, when switching from endocardial to 
epicardial pacing, the QT interval, Tpeak-end (Tp-Te) and TDR are unchanged in homogenous myocardium but 
prolonged in heterogenous myocardium. Modified and reprinted with permission from Lippincott Williams & 
Wilkins.8
            In humans, reversal of the normal sequence of activation has similarly been linked to 
arrhythmogenesis. Medina-Ravell et al7 showed that, in one patient, switching from endocardial 
to epicardial left ventricular pacing, the QT interval increased from 485 to 580 ms, an effect 
which was associated with the development of torsade-de-pointes ventricular tachycardia. 
(Figure 4) Switching from right ventricular endocardial pacing to BiVP led to an increase in the 
T interval followed by R-on-T ventricular extrasystoles. Importantly, a substudy of 29 patients 
with heart failure showed that LV epicardial pacing and BiVP led to increases in QT, JT and 
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transmural dispersion of depolarisation.7 (Figure 5) These data suggest that a BiVP- or LV 
epicardial-dependent increase in the QT interval and transmural dispersion of repolarisation has 
the potential for increasing the risk for the development of ventricular arrhythmias.
Figure 3. Effects of endocardial pacing (Endo-P) and epicardial pacing (Epi-P) on: (A) QT interval duration and (B) 
TDR in arterially perfused rabbit left ventricular preparations with and without the administration of dofetilide. Note 
that epicardial Epi-P led to a more pronounced prolongation in TDR than the QT interval duration. Reproduced with 
permission   from   Lippincott   Williams   &   Wilkins.7                                                                       
Cardiac   resynchronisation   therapy,   arrhythmias   and   sudden   cardiac   death
            Early studies suggested that CRT exerts an antiarrhythmic effect. Paul's group showed 
that CRT significantly reduced ventricular ectopic counts when compared to isolated right 
ventricular pacing.24 In the Ventak CHF trial (single-blinded, randomised, cross over study of 
CRT-D for 3 months, followed by 3 months of no pacing plus implantable cardioverter 
defibrillator), Higgins et al observed a lower frequency of antitachycardia therapies during BiVP 
compared to no pacing (16% v 34% respectively; p=0.04).25 
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Figure 4. Changes in QT interval, R-on-T ventricular extrasystoles and the development of torsade-de-pointes 
ventricular tachycardia in response to pacing at different sites. After switching from right ventricular endocardial 
pacing (RVEndoP) to left ventricular epicardial pacing (LVEpiP), the QT interval increased. Continued LVEpiP led 
to ventricular extrasystoles (B) and, eventually, to torsade-de-pointes ventricular tachycardia (C). Switching from 
RVEndoP to biventricular pacing (BiVP) led to an increase in the QT interval duration and to the emergence of R-
on-T   ventricular   extrasystoles.   Reproduced   with   permission   from   Lippincott   Williams   &   Wilkins.7
            Although the CARE-HF Extension study reported a reduction in sudden cardiac death 
following CRT,26 such an effect was not apparent after the initial 29 months' follow-up (CRT: 
35% versus medical therapy alone: 32%).1 A meta-analysis of randomised trials of CRT, which 
did not include the CARE-HF study, showed that while CRT reduces death from progressive 
heart failure, death from causes other than pump failure may have been increased.27  A 
subsequent meta-analysis of randomised trials which did include CARE-HF found no effect 
from CRT on sudden cardiac death.6 In balance, it would appear that CRT exerts its beneficial 
effects on mortality by reducing mortality from pump failure, rather than from arrhythmic 
events.  
            Increasing interest is being focused on factors which might predict benefit from CRT. A 
panoply of echocardiographic studies have explored numerous measures of dyssynchrony,28 but 
only 3 small studies have included mortality and cardiovascular events as endpoints. None of 
these echocardiographic measures have been validated against mortality or morbidity and no 
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echocardiographic parameters have been shown to predict arrhythmic events. With respect to the 
possible value of the ECG prior to implantation, QRS duration is not a predictor of benefit. 
Figure 5.  QT interval (●) and JT interval (○) duration during baseline rhythm, right ventricular endocardial, 
biventricular and left ventricular epicardial pacing in 29 patients with heart failure. Reproduced with permission 
from   Lippincott   Williams   &   Wilkins.7                                                                                   
            We sought to determine whether QT interval duration and QT dispersion prior to and 
following implantation predict major arrhythmic events (MAE) following CRT.29 In a study of 
75 patients, 11 patients suffered a MAE over a follow-up of 807 days. Disappointingly, neither 
the QT interval or QT dispersion prior to implantation predicted MAE. Following CRT, 
however, a differential effect of CRT on QT dispersion was observed, with 47% of patients 
exhibiting an increase in QT dispersion above baseline, and 53% showing a decrease. (Figure 
6). Major arrhythmic events occurred in 29% of patients exhibiting an increase in QT dispersion 
and in 3% of those exhibiting a decrease (p=0.0017). In multiple regression analyses, change in 
QT dispersion from baseline strongly predicted MAE, independently of changes in QTc, QRS 
duration, left ventricular ejection fraction and end-diastolic volume (p<0.001). Differences in 
survival curves were observed when patients were dichotomised according to whether QT 
dispersion increased or decreased in relation to baseline values (p<0.0001). (Figure 7) These 
findings raise the possibility that CRT has differential effects on the arrhythmogenic substrate, 
antiarrhythmic in some and arrhythmogenic in others. Similar differential effects on the 
arrhythomogenic   substrate   have   been   observed   with   other   treatments,   such   as   class   I 
antiarrhythmic agents.30 
            With regard to the Tpeak-Tend interval following CRT, we found that CRT led to an 
overall reduction in the Tpeak-Tend interval, averaging -16.5 ms for a cohort of  75 patients.29 The 
reduction, however, was more marked in the no-MAE than in the MAE group (-20.0±5.4 and 
-1.5±12.8 ms, respectively, p=0.047). Berger et al (31) also found that CRT leads to an overall 
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echocardiographic parameters have been shown to predict arrhythmic events. With respect to the 
possible value of the ECG prior to implantation, QRS duration is not a predictor of benefit. 
reduction in Tpeak-Tend of 81 ±  13.8 ms (mean ± SD). It would appear from this standard 
deviation that a reduction in Tpeak-Tend interval was not found in all patients. The salient finding 
from our study is that CRT has a differential effect on the the Tpeak-Tend interval and that this is 
related to the development of MAE.
Figure 6. Box plots of baseline QTc interval duration and QT dispersion and their changes from baseline to 48 days 
following cardiac resynchronization therapy. The five horizontal lines represent the 10th, 25th, 50th, 75th and 90th 
percentiles   of   each   variable,   from   bottom   to   top.   Reproduced   with   permission   from   Elsevier.29
Figure 7. Kaplan-Meier survival curves according to change in QT dispersion (QTD) from baseline to 48 days 
following   biventricular   pacemaker   implantation.   Reproduced   with   permission   from   Elsevier.29
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            Our demonstration that CRT is apparently proarrhythmic is some patients is relevant to 
the observation from the CARE-HF study that CRT reduces all-cause mortality but not sudden 
cardiac death.1 Arguably, the favourable effects of CRT on mortality are partly negated by an 
increase in the risk of death from fatal arrhythmias. Our findings are also relevant to the 
secondary end-point data from the Comparison of Medical Therapy, Pacing and Defibrillation in 
Heart Failure  (COMPANION) trial,4 which reported that all-cause mortality was lower in the 
CRT and CRT-D groups than in the pharmacological group after 12 months (15% and 12% 
compared to 19%, p=0.059 and p=0.003, respectively). Interestingly, the survival curves for all-
cause mortality begin to separate between day 270 and 360 after randomisation. Our finding that 
pacing-induced increases in QT dispersion becomes apparent around that time, between day 350 
and 450 post-implantation, may not be coincidental.                                                           
Modulation of  QT dispersion                                                                               
            As discussed above, CRT appears to have a differential effect on QT dispersion, which is 
related to the risk of developing ventricular tachyarrhythmias. No studies have explored which 
factors are responsible for this differential effect. Intuitively, patients with worse left ventricular 
function may be at an increased risk. In this respect, Pai et al have shown that in patients with 
heart failure, QT dispersion is negatively related to ejection fraction.22 In a study of 103 patients 
with ischaemic cardiomyopathy, Bountinoukos et al studied QT dispersion in relation to 
myocardial viability, assessed using dobutamine stress echocardiography.32  This group found 
that QT dispersion was lower in patients with at least 4 viable myocardial segments than in 
patients with no viability. These findings are supported by those Schinkel et al, who employed 
single photon emission cardiac tomography for assessing viability.33                                        
            Perfusion may also influence the arrhythmogenic substrate. Bonnemeier et al have shown 
that QT dynamicity, a temporal measure of QT dispersion, is increased following percutaneous 
coronary intervention in patients with TIMI 2 flow, compared to patients with TIMI 3 flow,34 
suggesting that the arrhythmogenic substrate is potentiated by incomplete revascularisation. The 
finding that surgical revascularisation reduces QT dispersion35 is consistent with this finding.    
               It   is   well   established   that   in   patients   with   ischaemic36-38  and   non-ischaemic 
cardiomyopathy,39 re-entrant circuits in the border zone surrounding myocardial scars are the 
source of ventricular tachycardia. Currently, left ventricular leads during implantation for CRT 
are placed without regard to the site of myocardial scars. Epicardial pacing in the border zone of 
a scar may, conceivably, be arrhythmogenic.                                                                   
            Ventricular dyssynchrony may also influence the arrhythmogenic substrate. In the study 
of Spragg et al,40 adult dogs underwent left bundle branch radiofrequency ablation and tagged 
MR imaging to confirm left ventricular dyssynchrony. Four weeks later, hearts were excised and 
myocardial segments were isolated. Interestingly, conduction velocity, action potential duration 
and   refractory   period   were   significantly   reduced   in   the   late-activated,   lateral   wall   of 
dyssynchronous hearts compared to the anterior wall. Moreover, the normal difference in 
conduction velocity between the endocardial and pericardial layers were reversed in the 
dyssynchronous lateral wall. The subcellular location of conexin43 was redistributed in late-
activated myocardium from intercalated discs to lateral myocyte membranes. The salient finding 
from this study is that dyssynchrony alone induces regionally specific changes in conduction and 
repolarisation. Whether or not dyssynchorny is in itself proarrhythmic has not been explored. 
Nor have any studies focused on the possibility that incomplete resynchronisation might be 
responsible for increased arrhythmogenesis.                                                                     
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Conclusions and implications for further research                                                                       
            The incidence of sudden, presumed arrhythmic, deaths in patients with heart failure 
treated with CRT remains high, comparable to patients receiving pharmacological therapy alone. 
Both animal and human experimental evidence indicates that reversal of the normal direction of 
myocardial activation, as it occurs during conventional CRT, promotes arrhythmogenesis. Such 
findings are consistent with human experiments showing that epicardial pacing leads to 
increased transmural dispersion of repolarisation and ventricular arrhythmias. Studies of patients 
undergoing CRT have shown that CRT has a differential effect on QT dispersion, with some 
patients exhibiting an increase above pre-implant values. Such an increase in QT dispersion 
carries   a   risk   of   arrhythmic   events.                                                                  
            Little is known about which factors might modulate the arhythmogenic substrate in 
patients undergoing CRT. Identification of factors that render some patients susceptible to the 
putative arrhythmogenic effects of CRT may be useful in patient selection. Further studies are 
needed to determine whether underlying left ventricular function, dyssynchrony and the site of 
the LV pacing lead in relation to myocardial scars are relevant in this respect. An alternative 
solution to the apparent arrhythmogenic effects of CRT is to use LV endocardial pacing, as this 
would preserve the natural direction of myocardial activation. 
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